153 related articles for article (PubMed ID: 22525581)
1. Selective treatment of mixed-lineage leukemia leukemic stem cells through targeting glycogen synthase kinase 3 and the canonical Wnt/β-catenin pathway.
Fung TK; Gandillet A; So CW
Curr Opin Hematol; 2012 Jul; 19(4):280-6. PubMed ID: 22525581
[TBL] [Abstract][Full Text] [Related]
2. β-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells.
Yeung J; Esposito MT; Gandillet A; Zeisig BB; Griessinger E; Bonnet D; So CW
Cancer Cell; 2010 Dec; 18(6):606-18. PubMed ID: 21156284
[TBL] [Abstract][Full Text] [Related]
3. GPR84 sustains aberrant β-catenin signaling in leukemic stem cells for maintenance of MLL leukemogenesis.
Dietrich PA; Yang C; Leung HH; Lynch JR; Gonzales E; Liu B; Haber M; Norris MD; Wang J; Wang JY
Blood; 2014 Nov; 124(22):3284-94. PubMed ID: 25293777
[TBL] [Abstract][Full Text] [Related]
4. The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML.
Wang Y; Krivtsov AV; Sinha AU; North TE; Goessling W; Feng Z; Zon LI; Armstrong SA
Science; 2010 Mar; 327(5973):1650-3. PubMed ID: 20339075
[TBL] [Abstract][Full Text] [Related]
5. PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS/HOX pathway.
Zhou J; Wu J; Li B; Liu D; Yu J; Yan X; Zheng S; Wang J; Zhang L; Zhang L; He F; Li Q; Chen A; Zhang Y; Zhao X; Guan Y; Zhao X; Yan J; Ni J; Nobrega MA; Löwenberg B; Delwel R; Valk PJ; Kumar A; Xie L; Tenen DG; Huang G; Wang QF
Leukemia; 2014 Jul; 28(7):1436-48. PubMed ID: 24445817
[TBL] [Abstract][Full Text] [Related]
6. 3-methoxyapigenin modulates β-catenin stability and inhibits Wnt/β-catenin signaling in Jurkat leukemic cells.
Chuang KA; Lieu CH; Tsai WJ; Huang WH; Lee AR; Kuo YC
Life Sci; 2013 Apr; 92(12):677-86. PubMed ID: 23333831
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathways: epigenetic modulation of Wnt-glycogen synthase kinase-3 signaling to target human cancer stem cells.
Benoit YD; Guezguez B; Boyd AL; Bhatia M
Clin Cancer Res; 2014 Nov; 20(21):5372-8. PubMed ID: 25006223
[TBL] [Abstract][Full Text] [Related]
8. Menin as a hub controlling mixed lineage leukemia.
Thiel AT; Huang J; Lei M; Hua X
Bioessays; 2012 Sep; 34(9):771-80. PubMed ID: 22829075
[TBL] [Abstract][Full Text] [Related]
9. Intracellular Signals Activated by Canonical Wnt Ligands Independent of GSK3 Inhibition and β-Catenin Stabilization.
García de Herreros A; Duñach M
Cells; 2019 Sep; 8(10):. PubMed ID: 31557964
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase 3 inhibitors induce the canonical WNT/β-catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma.
Chen EY; DeRan MT; Ignatius MS; Grandinetti KB; Clagg R; McCarthy KM; Lobbardi RM; Brockmann J; Keller C; Wu X; Langenau DM
Proc Natl Acad Sci U S A; 2014 Apr; 111(14):5349-54. PubMed ID: 24706870
[TBL] [Abstract][Full Text] [Related]
11. GSK3 Inhibits Macropinocytosis and Lysosomal Activity through the Wnt Destruction Complex Machinery.
Albrecht LV; Tejeda-Muñoz N; Bui MH; Cicchetto AC; Di Biagio D; Colozza G; Schmid E; Piccolo S; Christofk HR; De Robertis EM
Cell Rep; 2020 Jul; 32(4):107973. PubMed ID: 32726636
[TBL] [Abstract][Full Text] [Related]
12. GSK3-activated STAT5 regulates expression of SFRPs to modulate adipogenesis.
Wang L; Wang Y; Meng Y; Zhang C; Di L
FASEB J; 2018 Sep; 32(9):4714-4726. PubMed ID: 29579399
[TBL] [Abstract][Full Text] [Related]
13. Targeting the Wnt/β-catenin signaling pathway in cancer.
Zhang Y; Wang X
J Hematol Oncol; 2020 Dec; 13(1):165. PubMed ID: 33276800
[TBL] [Abstract][Full Text] [Related]
14. [TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in human acute myeloid leukemia].
Sakoda T; Kikushige Y
Rinsho Ketsueki; 2023; 64(6):547-552. PubMed ID: 37407480
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Glycogen Synthase Kinase Inhibitors That Regulate Cytochrome P450 Expression in Primary Human Hepatocytes by Activation of β-Catenin, Aryl Hydrocarbon Receptor and Pregnane X Receptor Signaling.
Briolotti P; Chaloin L; Balaguer P; Da Silva F; Tománková V; Pascussi JM; Duret C; Fabre JM; Ramos J; Klieber S; Maurel P; Daujat-Chavanieu M; Gerbal-Chaloin S
Toxicol Sci; 2015 Nov; 148(1):261-75. PubMed ID: 26259606
[TBL] [Abstract][Full Text] [Related]
16. Wnt Signaling in Leukemia and Its Bone Marrow Microenvironment.
Ruan Y; Kim HN; Ogana H; Kim YM
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872365
[TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy.
Wang Z; Smith KS; Murphy M; Piloto O; Somervaille TC; Cleary ML
Nature; 2008 Oct; 455(7217):1205-9. PubMed ID: 18806775
[TBL] [Abstract][Full Text] [Related]
18. Cell Biology of Canonical Wnt Signaling.
Albrecht LV; Tejeda-Muñoz N; De Robertis EM
Annu Rev Cell Dev Biol; 2021 Oct; 37():369-389. PubMed ID: 34196570
[TBL] [Abstract][Full Text] [Related]
19. GSK3: a multifaceted kinase in Wnt signaling.
Wu D; Pan W
Trends Biochem Sci; 2010 Mar; 35(3):161-8. PubMed ID: 19884009
[TBL] [Abstract][Full Text] [Related]
20. Activation of Wnt signaling in cKit-ITD mediated transformation and imatinib sensitivity in acute myeloid leukemia.
Tickenbrock L; Hehn S; Sargin B; Evers G; Ng PR; Choudhary C; Berdel WE; Müller-Tidow C; Serve H
Int J Hematol; 2008 Sep; 88(2):174-180. PubMed ID: 18668305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
